Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,843 | 11,155 | 14,625 | 5,145 | 6,877 |
| Other current assets | 0 | 0 | 0 | 0 | 700 |
| TOTAL | $9,232 | $12,487 | $16,216 | $6,792 | $9,457 |
| Non-Current Assets | |||||
| PPE Net | 51 | 38 | 37 | 157 | 155 |
| Other Non-Current Assets | 6 | 6 | 4 | 4 | 15 |
| TOTAL | $57 | $44 | $41 | $161 | $170 |
| Total Assets | $9,289 | $12,531 | $16,257 | $6,953 | $9,627 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,079 | 773 | 142 | 584 | 213 |
| Accrued Expenses | 153 | N/A | 885 | N/A | 16 |
| TOTAL | $1,232 | $773 | $1,027 | $584 | $229 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,232 | $773 | $1,027 | $584 | $229 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7 | 7 | 7 | 5 | 5 |
| Common Shares | 58 | 58 | 58 | 45 | 45 |
| Retained earnings | -89,652 | -85,096 | -81,258 | -77,034 | -73,666 |
| TOTAL | $8,057 | $11,758 | $15,230 | $6,369 | $9,398 |
| Total Liabilities And Equity | $9,289 | $12,531 | $16,257 | $6,953 | $9,627 |